TY - JOUR
T1 - The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
AU - Yang, Haitao
AU - Yang, Maojun
AU - Ding, Yi
AU - Liu, Yiwei
AU - Lou, Zhiyong
AU - Zhou, Zhe
AU - Sun, Lei
AU - Mo, Lijuan
AU - Ye, Sheng
AU - Pang, Hai
AU - Gao, George F.
AU - Anand, Kanchan
AU - Bartlam, Mark
AU - Hilgenfeld, Rolf
AU - Rao, Zihe
PY - 2003/11/11
Y1 - 2003/11/11
N2 - A newly identified severe acute respiratory syndrome coronavirus (SARS-CoV), is the etiological agent responsible for the outbreak of SARS. The SARS-CoV main protease, which is a 33.8-kDa protease (also called the 3C-like protease), plays a pivotal role in mediating viral replication and transcription functions through extensive proteolytic processing of two replicase polyproteins, pp1a (486 kDa) and pp1ab (790 kDa). Here, we report the crystal structures of the SARS-CoV main protease at different pH values and in complex with a specific inhibitor. The protease structure has a fold that can be described as an augmented serine-protease, but with a Cys-His at the active site. This series of crystal structures, which is the first, to our knowledge, of any protein from the SARS virus, reveal substantial pH-dependent conformational changes, and an unexpected mode of inhibitor binding, providing a structural basis for rational drug design.
AB - A newly identified severe acute respiratory syndrome coronavirus (SARS-CoV), is the etiological agent responsible for the outbreak of SARS. The SARS-CoV main protease, which is a 33.8-kDa protease (also called the 3C-like protease), plays a pivotal role in mediating viral replication and transcription functions through extensive proteolytic processing of two replicase polyproteins, pp1a (486 kDa) and pp1ab (790 kDa). Here, we report the crystal structures of the SARS-CoV main protease at different pH values and in complex with a specific inhibitor. The protease structure has a fold that can be described as an augmented serine-protease, but with a Cys-His at the active site. This series of crystal structures, which is the first, to our knowledge, of any protein from the SARS virus, reveal substantial pH-dependent conformational changes, and an unexpected mode of inhibitor binding, providing a structural basis for rational drug design.
UR - https://www.scopus.com/pages/publications/0345255626
U2 - 10.1073/pnas.1835675100
DO - 10.1073/pnas.1835675100
M3 - 文章
C2 - 14585926
AN - SCOPUS:0345255626
SN - 0027-8424
VL - 100
SP - 13190
EP - 13195
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 23
ER -